Meet with us at Rare Trials Summit 2026!

Join us at Rare Trials Summit 2026, where biopharma leaders, patient advocates, investigators, CROs, and technology partners come together to address the unique challenges of rare disease clinical development. 

With experience across 88 rare disease indications, including rare cancers and ultra-rare conditions, Premier Research helps sponsors navigate regulatory, operational, and patient recruitment challenges through integrated expertise in study design, global clinical operations, and patient engagement. 

Featured Session: 

Retention by Design: Keeping Families Engaged for Multi-Year Studies

We’ll discuss practical strategies to improve long-term participant engagement, reduce family burden, and support retention in multi-year rare disease studies. 

• Date: Tuesday, September 15 | 1:45–2:30 PM EDT 
• Speaker: Angi Robinson, Sr. Vice President, Specialty Areas

Connect with our team to learn more about: 

• Regulatory strategy and orphan drug development  
• Innovative study design and natural history studies  
• Patient recruitment, engagement, and retention 
• Global clinical operations for complex rare disease trials 

On-Site

• Paul Spreen, Chief Commercial Officer
• Angi Robinson, Sr. Vice President, Specialty Areas
• Jenny Anderson, Vice President, Go to Market Strategy & Operations
• Paulla Dennis, Executive Director, Program Strategy, Specialty Areas

Request a Meeting With Us

Let’s discuss how our rare disease expertise can help move your program forward.